Preparing for Your First Ultherapy Session: Tips and Tricks

Ultherapy is gaining popularity as a non-surgical alternative for skin tightening and rejuvenation. This innovative treatment leverages ultrasound technology to boost collagen production, providing a natural lift to the skin. If you’ve booked your first Ultherapy session, you might be wondering what steps to take to ensure the best results. This article serves as your go-to guide from Metro Beauty Centers which provides ultherapy in Bangkok for preparing for your first Ultherapy appointment, offering essential tips and tricks to maximize benefits.

What is Ultherapy?

Ultherapy is an FDA-cleared procedure that uses ultrasound energy to stimulate the production of collagen, a protein responsible for skin elasticity. Unlike surgical procedures such as facelifts, Ultherapy doesn’t involve cuts, anaesthesia, or downtime. The treatment is most commonly used to target sagging skin on the face, neck, and décolletage.

Consult Your Specialist

Before jumping into the actual procedure, consult a qualified specialist to assess your skin condition. This initial conversation allows the expert to tailor the treatment to your specific needs, giving you a chance to address any concerns you might have. You’ll also discuss your medical history to rule out any contraindications.

Pre-Treatment Dos and Don’ts

Dos

Hydration

Well-hydrated skin responds better to ultrasound energy. Prioritize hydration by drinking lots of water in the lead-up to your upcoming session.

Balanced Diet

Eating a balanced diet rich in vitamins and minerals will prepare your skin for the procedure. Focus on foods that are high in antioxidants like fruits and vegetables.

Gentle Skincare

In the week before the session, opt for gentle skincare products free of harsh chemicals. This will help minimize the risk of irritation post-treatment.

Don’ts

Sun Exposure

Limit your exposure to the sun for at least a week before the treatment. UV rays can irritate your skin and may affect the results.

No Waxing or Peels

Avoid any waxing, chemical peels, or laser treatments in the area you plan to have treated for at least a week prior.

Avoid Blood-Thinning Medications

Consult your doctor if you’re taking any medications that could thin your blood, like aspirin or certain anti-inflammatory drugs.

On The Day Of The Treatment

What to Wear

Choose loose, comfortable clothing. You’ll likely need to remove clothing from the area being treated, so easy-to-remove items are best.

Skincare Preparations

Make sure your skin is clean and free of any make-up, lotions, or creams. This allows the ultrasound gel used during the treatment to make optimal contact with your skin.

Eating and Drinking

It’s generally okay to eat and drink normally before Ultherapy. However, some people prefer to eat lightly to avoid any potential discomfort.

What To Expect During the Procedure

Ultherapy typically lasts between 30 to 90 minutes, depending on the area being treated. You’ll feel tiny amounts of energy being delivered beneath the skin, which is how Ultherapy stimulates collagen production. The sensation is tolerable, but you can always discuss pain relief options with your specialist.

Post-Treatment Care

After the treatment, you might notice mild redness, swelling, or tingling in the treated area. Generally, these side effects are short-lived and tend to fade away within several hours. It’s crucial to follow any post-care instructions provided by your specialist.

Final Thoughts

Preparing for your first Ultherapy session doesn’t have to be daunting. By following these practical tips and tricks, you’re setting yourself up for a successful treatment with long-lasting results. Always consult with a certified specialist to ensure that Ultherapy is the right choice for your skincare needs. Remember, personalized advice from a qualified professional is invaluable when it comes to any medical treatment. So, ready to say hello to rejuvenated skin? With adequate preparation, your first Ultherapy experience can be both enjoyable and rewarding.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”